A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is application/pdf.
18F-FDG PET for evaluation of the treatment response in patients with gastrointestinal tract lymphomas
2004
Journal of Nuclear Medicine
Preserved Fulltext
(18)F-FDG PET is highly sensitive and specific for evaluation of the treatment response of nodal and extranodal diseases in patients with malignant lymphomas. However, no data are available in the literature with regard to (18)F-FDG PET for evaluation of the treatment response in patients with lymphomas with gastrointestinal tract (GIT) involvement. This study was undertaken to investigate the usefulness of (18)F-FDG PET in monitoring the response to the treatment of lymphomas in this setting.
pmid:15534046
fatcat:mrwjbqcpgjaxzj4mniaqljg5gy